The Name of the #1 Stock to Trade in 2021

From Legacy Research | Ad

Expert Jeff Clark is releasing his #1 stock to trade in 2021.

Since he started recommending this stock, you could have used it for gains as high as 269% and even 273%... in as little as 8 days.

Click here now and get its name.

ZLAB Insider Trading (Zai Lab)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $24,294,391.62

Zai Lab Insider Trading History Chart

Zai Lab Share Price & Price History

^$158.14

▲ +2.56 (1.65%)

As of 05/7/2021 01:00 AM ET

Days: 30 | 90 | 365

Buy These 3 Cryptos to Beat Bitcoin

From IPM | Ad

The cryptocurrency market is exploding in value right now...

Bitcoin broke through $60,000... And dozens of cryptos have gone up more than 1,000%...

If you’re ready to start capitalizing on this massive boom, legendary crypto investor Matt McCall just released a new free report, “3 Cryptos to Beat Bitcoin.”

You can claim your free report by clicking here.

Zai Lab Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/5/2021	John D Diekman	Director	Sell	1,000	$153.62	$153,620.00	62,852
5/3/2021	Ying Du	CEO	Sell	62,164	$161.57	$10,043,837.48	889,331
4/21/2021	Harald Reinhart	Insider	Sell	16,000	$156.10	$2,497,600.00	8,000
4/19/2021	Tao Fu	COO	Sell	10,000	$162.91	$1,629,100.00	217,000
4/7/2021	Ying Du	CEO	Sell	21,936	$134.42	$2,948,637.12	1,008,653
4/5/2021	Ying Du	CEO	Sell	50,784	$126.19	$6,408,432.96	1,008,653
3/12/2021	Kai-Xian Chen	Director	Sell	4,302	$142.53	$613,164.06	24,662

SEC Filings (Institutional Ownership Changes) for Zai Lab (NASDAQ:ZLAB)

81.32% of Zai Lab stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Zai Lab Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2021	BlackRock Inc.	3,731,079	$497.84M	0.0%	+4.1%	4.183%
5/7/2021	American International Group Inc.	953	$0.13M	0.0%	+45.9%	0.001%
5/7/2021	BNP Paribas Arbitrage SA	123,375	$16.46M	0.0%	+75.6%	0.138%
5/7/2021	Swiss National Bank	176,471	$23.55M	0.0%	+4.7%	0.198%
5/6/2021	Quantitative Systematic Strategies LLC	4,912	$0.66M	0.1%	+71.9%	0.006%
5/6/2021	Matthews International Capital Management LLC	231,700	$30.92M	1.3%	+10,933.3%	0.260%
5/6/2021	Prospera Financial Services Inc	2,824	$0.38M	0.0%	+33.8%	0.003%
5/6/2021	Alliancebernstein L.P.	20,989	$2.80M	0.0%	+39.3%	0.024%
5/6/2021	Baillie Gifford & Co.	3,865,124	$515.72M	0.3%	+0.4%	4.333%
5/6/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	16,642	$2.22M	0.0%	+11.8%	0.019%
5/6/2021	Standard Life Aberdeen plc	6,053	$0.81M	0.0%	+22.0%	0.007%
5/6/2021	M&T Bank Corp	2,132	$0.28M	0.0%	-8.5%	0.002%
5/4/2021	Envestnet Asset Management Inc.	2,887	$0.39M	0.0%	+49.3%	0.003%
5/4/2021	Victory Capital Management Inc.	16,056	$2.14M	0.0%	-4.9%	0.018%
5/3/2021	The Manufacturers Life Insurance Company	11,500	$1.53M	0.0%	-8.0%	0.013%
5/3/2021	Calton & Associates Inc.	1,945	$0.26M	0.1%	-17.6%	0.002%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	21,580	$2.88M	0.0%	+30.5%	0.024%
4/30/2021	Signaturefd LLC	676	$90K	0.0%	+82.2%	0.001%
4/30/2021	Exane Derivatives	329	$44K	0.0%	N/A	0.000%
4/30/2021	Sumitomo Mitsui Trust Holdings Inc.	182,900	$24.40M	0.0%	+1.9%	0.205%
4/30/2021	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	29,900	$3.99M	0.0%	+2.0%	0.034%
4/29/2021	Handelsbanken Fonder AB	24,300	$3.24M	0.0%	-5.1%	0.027%
4/28/2021	US Bancorp DE	2,198	$0.29M	0.0%	+7.9%	0.002%
4/28/2021	DekaBank Deutsche Girozentrale	22,025	$2.82M	0.0%	+7.4%	0.025%
4/28/2021	Comerica Bank	5,889	$1.02M	0.0%	+3.4%	0.007%
4/27/2021	CWM LLC	550	$73K	0.0%	N/A	0.001%
4/27/2021	State of New Jersey Common Pension Fund D	27,616	$3.69M	0.0%	+36.8%	0.031%
4/26/2021	KBC Group NV	8,801	$1.17M	0.0%	-14.8%	0.010%
4/26/2021	Cordatus Wealth Management LLC	2,824	$0.38M	0.1%	+33.8%	0.003%
4/26/2021	Assenagon Asset Management S.A.	48,616	$6.49M	0.0%	-74.3%	0.055%
4/23/2021	Parallel Advisors LLC	306	$41K	0.0%	+50.7%	0.000%
4/23/2021	WT Asset Management Ltd	27,900	$3.72M	0.6%	N/A	0.031%
4/20/2021	MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH	4,200	$0.56M	0.1%	N/A	0.005%
4/16/2021	Harbor Investment Advisory LLC	226	$30K	0.0%	N/A	0.000%
4/15/2021	Crossmark Global Holdings Inc.	2,610	$0.35M	0.0%	N/A	0.003%
4/13/2021	Redpoint Investment Management Pty Ltd	7,643	$1.02M	0.1%	N/A	0.009%
4/13/2021	Golden Green Inc.	3,032	$0.41M	0.3%	N/A	0.003%
4/13/2021	E Fund Management Hong Kong Co. Ltd.	18,866	$2.52M	0.8%	+3.6%	0.021%
4/12/2021	Calamos Advisors LLC	3,761	$0.50M	0.0%	-82.7%	0.004%
3/12/2021	DekaBank Deutsche Girozentrale	20,506	$2.65M	0.0%	+17.6%	0.023%
3/10/2021	HM Payson & Co.	567	$77K	0.0%	-19.0%	0.001%
3/8/2021	B. Metzler seel. Sohn & Co. Holding AG	2,602	$0.35M	0.0%	N/A	0.003%
3/4/2021	Hudson Bay Capital Management LP	364,465	$49.33M	0.4%	+11.3%	0.414%
3/2/2021	Norges Bank	833,486	$112.80M	0.0%	N/A	1.434%
3/1/2021	UBS Asset Management Americas Inc.	359,463	$48.65M	0.0%	+54.0%	0.619%
2/19/2021	PFM Health Sciences LP	107,061	$14.49M	0.5%	N/A	0.184%
2/19/2021	JPMorgan Chase & Co.	279,150	$37.78M	0.0%	-35.1%	0.480%
2/17/2021	Voloridge Investment Management LLC	9,250	$1.25M	0.0%	-85.8%	0.016%
2/17/2021	Canada Pension Plan Investment Board	212,486	$28.76M	0.0%	+444.7%	0.366%
2/16/2021	Tri Locum Partners LP	62,235	$8.42M	3.1%	N/A	0.107%
2/16/2021	Morgan Stanley	78,882	$10.68M	0.0%	-37.0%	0.136%
2/16/2021	Nuveen Asset Management LLC	147,250	$19.93M	0.0%	+23.6%	0.253%
2/16/2021	Price T Rowe Associates Inc. MD	908,829	$123M	0.0%	+34.3%	1.564%
2/16/2021	Clough Capital Partners L P	115,540	$15.64M	1.1%	-32.5%	0.199%
2/16/2021	Kingsview Wealth Management LLC	3,296	$0.45M	0.0%	+17.3%	0.006%
2/16/2021	ETF Managers Group LLC	20,787	$2.79M	0.1%	-20.8%	0.036%
2/16/2021	Janus Henderson Group PLC	34,628	$4.69M	0.0%	+30.5%	0.060%
2/16/2021	Charles Schwab Investment Management Inc.	82,982	$11.23M	0.0%	+3.5%	0.143%
2/12/2021	Caisse DE Depot ET Placement DU Quebec	11,119	$1.51M	0.0%	-13.1%	0.019%
2/12/2021	Bamco Inc. NY	2,046,155	$276.93M	0.7%	+1.1%	3.521%
2/12/2021	Penserra Capital Management LLC	1,275	$0.17M	0.0%	+171.3%	0.002%
2/12/2021	Federated Hermes Inc.	1,990,860	$269.44M	0.6%	0.0%	3.426%
2/12/2021	The Manufacturers Life Insurance Company	12,500	$1.69M	0.0%	+35.9%	0.022%
2/12/2021	Qtron Investments LLC	15,292	$2.07M	0.6%	+22.7%	0.026%
2/12/2021	Credit Suisse AG	1,489,358	$201.57M	0.1%	+12.5%	2.563%
2/12/2021	Nomura Asset Management Co. Ltd.	4,860	$0.66M	0.0%	+44.2%	0.008%
2/12/2021	Prospera Financial Services Inc	2,110	$0.29M	0.0%	N/A	0.004%
2/12/2021	Tree Line Advisors Hong Kong Ltd.	782,000	$105.84M	17.9%	-10.6%	1.346%
2/12/2021	Vontobel Holding Ltd.	6,550	$1.20M	0.0%	N/A	0.011%
2/12/2021	M&T Bank Corp	2,330	$0.32M	0.0%	N/A	0.004%
2/11/2021	Krane Funds Advisors LLC	31,374	$4.25M	0.2%	+35.6%	0.054%
2/11/2021	Wetherby Asset Management Inc.	2,454	$0.33M	0.0%	N/A	0.004%
2/11/2021	Trexquant Investment LP	2,647	$0.36M	0.0%	N/A	0.005%
2/11/2021	Northern Trust Corp	295,305	$39.97M	0.0%	+3.2%	0.508%
2/11/2021	Citigroup Inc.	56,029	$7.58M	0.0%	+21.5%	0.096%
2/11/2021	Handelsbanken Fonder AB	25,600	$3.47M	0.0%	N/A	0.044%
2/11/2021	Nicholas Investment Partners LP	88,871	$12.03M	0.9%	N/A	0.153%
2/11/2021	Zeal Asset Management Ltd	1,424,632	$188.34M	36.7%	-13.8%	2.452%
2/11/2021	Signaturefd LLC	371	$50K	0.0%	+77.5%	0.001%
2/11/2021	Syntal Capital Partners LLC	13,936	$1.89M	0.2%	N/A	0.024%
2/10/2021	Mackenzie Financial Corp	42,101	$5.70M	0.0%	N/A	0.072%
2/10/2021	Clearbridge Investments LLC	378,113	$51.17M	0.0%	-7.8%	0.651%
2/10/2021	QS Investors LLC	3,466	$0.47M	0.0%	N/A	0.006%
2/10/2021	Baillie Gifford & Co.	3,850,149	$521.08M	0.3%	+6.9%	6.626%
2/10/2021	Aviva PLC	22,270	$3.01M	0.0%	+26.0%	0.038%
2/10/2021	Panagora Asset Management Inc.	6,589	$0.89M	0.0%	+26.7%	0.011%
2/10/2021	KBC Group NV	10,333	$1.40M	0.0%	+110.3%	0.018%
2/10/2021	Korea Investment CORP	676	$91K	0.0%	N/A	0.001%
2/9/2021	Wells Fargo & Company MN	552,274	$74.75M	0.0%	+2.2%	0.950%
2/9/2021	Bank of New York Mellon Corp	133,678	$18.09M	0.0%	+11.6%	0.230%
2/9/2021	Quantitative Systematic Strategies LLC	2,857	$0.39M	0.1%	N/A	0.005%
2/9/2021	Matthews International Capital Management LLC	2,100	$0.28M	0.0%	-90.7%	0.004%
2/9/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	14,886	$2.02M	0.0%	+10.4%	0.026%
2/9/2021	ProShare Advisors LLC	8,596	$1.16M	0.0%	-3.2%	0.015%
2/9/2021	Profund Advisors LLC	1,648	$0.22M	0.0%	N/A	0.003%
2/8/2021	CIBC World Markets Inc.	5,462	$0.74M	0.0%	N/A	0.009%
2/8/2021	Alliancebernstein L.P.	15,070	$2.04M	0.0%	-44.1%	0.026%
2/8/2021	BP PLC	1,656	$0.22M	0.0%	N/A	0.003%
2/8/2021	FIL Ltd	231	$31K	0.0%	+34.3%	0.000%
2/8/2021	Russell Investments Group Ltd.	19,346	$2.61M	0.0%	+428.3%	0.033%

Data available starting January 2016

Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops, and commercializes therapeutics to treat oncology, autoimmune, and infectious diseases in China. The company offers ZEJULA for the treatment of breast cancer and non-small cell lung cancer (NSCLC); and Optune, a cancer therapy to treat glioblastoma multiforme. It also develops QINLOCK for the treatment of gastrointestinal stromal tumors; Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other lymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naÃ¯ve- or -pretreated cancer patients; Margetuximab for the treatment of breast and gastroesophageal cancers; Bemarituzumab for the treatment of gastric and gastroesophageal junction cancer; and Omadacycline to treat acute bacterial skin and skin structure, and community-acquired bacterial pneumonia infections. In addition, the company develops CLN-081 for the treatment of patients with EGFR exon 20 insertion NSCLC; Efgartigimod to reduce disease-causing immunoglobulin G (IgG) antibodies; Retifanlimab to treat microsatellite instability high endometrial cancer; ZL-2309 for the treatment of metastatic pancreatic cancer, metastatic colorectal cancer, and other advanced solid tumors; ZL-1201 to treat solid tumors and hematological malignancies; ZL-1102 for the treatment of psoriasis; and Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter. Zai Lab Limited has license and collaboration agreements with the GlaxoSmithKline; Paratek Bermuda, Ltd.; Five Prime Therapeutics, Inc.; Entasis Therapeutics Holdings, Inc.; Crescendo Biologics Ltd.; Novocure Limited; MacroGenics Inc.; Deciphera Pharmaceuticals, LLC; Incyte Corporation; Regeneron Ireland Designated Activity Company; Turning Point Therapeutics Inc; Cullinan Pearl Corp.; Takeda Pharmaceutical Company Limited; and argenx BV. The company was incorporated in 2013 and is headquartered in Shanghai, China.

Today's Range

Now: $158.14

$154.19

$159.74

50 Day Range

MA: $147.30

$125.11

$177.19

52 Week Range

Now: $158.14

$62.89

$193.54

Volume

586,076 shs

Average Volume

488,717 shs

Market Capitalization

$14.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Zai Lab?

Zai Lab's top insider shareholders include:

Ying Du (CEO)
Tao Fu (COO)
John D Diekman (Director)
Kai-Xian Chen (Director)
Harald Reinhart (Insider)

Who are the major institutional investors of Zai Lab?

Zai Lab's top institutional shareholders include:

Baillie Gifford & Co. — 4.33%
BlackRock Inc. — 4.18%
Matthews International Capital Management LLC — 0.26%
Sumitomo Mitsui Trust Holdings Inc. — 0.21%
Swiss National Bank — 0.20%
BNP Paribas Arbitrage SA — 0.14%

Which major investors are selling Zai Lab stock?

Within the previous quarter, ZLAB stock was sold by these institutional investors:

Assenagon Asset Management S.A.
Calamos Advisors LLC
KBC Group NV
Handelsbanken Fonder AB
The Manufacturers Life Insurance Company
Victory Capital Management Inc.
Calton & Associates Inc.
M&T Bank Corp

During the previous year, company insiders that have sold Zai Lab company stock include:

Ying Du (CEO)
Tao Fu (COO)
John D Diekman (Director)
Kai-Xian Chen (Director)
Harald Reinhart (Insider)

Which major investors are buying Zai Lab stock?

Within the previous quarter, ZLAB stock was bought by institutional investors including:

Matthews International Capital Management LLC
BlackRock Inc.
BNP Paribas Arbitrage SA
WT Asset Management Ltd
Baillie Gifford & Co.
Swiss National Bank
Redpoint Investment Management Pty Ltd
State of New Jersey Common Pension Fund D

The Name of the #1 Stock to Trade in 2021

From Legacy Research | Ad

Expert Jeff Clark is releasing his #1 stock to trade in 2021.

Since he started recommending this stock, you could have used it for gains as high as 269% and even 273%... in as little as 8 days.

Click here now and get its name.